Courage over Cancer Filtered Blog

American Cancer Society grant supports transportation access at Mays Cancer Center

New study aims to guide prostate cancer patients through early treatment decisions

  For more than 20 years, Lixin Song, PhD, RN, FAAN, vice dean for research and scholarship and professor of nursing at The University of Texas at San Antonio (UT San Antonio) School of Nursing, has studied how cancer patients and their families navigate the challenging experience of making decisions about treatment while facing uncertainty, […]

UT Health San Antonio Multispecialty and Research Hospital treats first clinical trial participant in novel cancer study

UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.

Mays Cancer Center physicians recognized on San Antonio Magazine Top Doctors list

Lymphedema myth busters: Separating fact from fear

UT Health San Antonio plastic surgeons Dr. Anton Fries and Dr. Oriana Haran join us to debunk common misconceptions.

Widely used metabolic drugs may help curb rising colorectal cancer in younger adults

A large, retrospective study conducted by scientists at The University of Texas at San Antonio suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin.